New York State Common Retirement Fund Sells 71,109 Shares of HealthEquity, Inc. (NASDAQ:HQY)

New York State Common Retirement Fund decreased its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 67.8% in the 4th quarter, Holdings Channel reports. The fund owned 33,700 shares of the company’s stock after selling 71,109 shares during the quarter. New York State Common Retirement Fund’s holdings in HealthEquity were worth $2,234,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently made changes to their positions in the company. McGlone Suttner Wealth Management Inc. bought a new position in shares of HealthEquity during the 4th quarter worth $29,000. DekaBank Deutsche Girozentrale bought a new position in shares of HealthEquity during the 3rd quarter worth $41,000. Fifth Third Bancorp grew its stake in shares of HealthEquity by 36.5% during the 3rd quarter. Fifth Third Bancorp now owns 602 shares of the company’s stock worth $44,000 after acquiring an additional 161 shares during the period. Operose Advisors LLC bought a new position in shares of HealthEquity during the 3rd quarter worth $44,000. Finally, Covestor Ltd boosted its stake in HealthEquity by 92.9% in the 3rd quarter. Covestor Ltd now owns 1,119 shares of the company’s stock worth $82,000 after purchasing an additional 539 shares during the period. Institutional investors own 99.55% of the company’s stock.

Insider Transactions at HealthEquity

In other HealthEquity news, EVP Delano Ladd sold 2,499 shares of the company’s stock in a transaction dated Friday, February 9th. The shares were sold at an average price of $80.00, for a total transaction of $199,920.00. Following the completion of the sale, the executive vice president now directly owns 49,996 shares in the company, valued at $3,999,680. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. In related news, EVP Delano Ladd sold 2,499 shares of the firm’s stock in a transaction that occurred on Friday, February 9th. The stock was sold at an average price of $80.00, for a total transaction of $199,920.00. Following the transaction, the executive vice president now directly owns 49,996 shares in the company, valued at approximately $3,999,680. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO Jon Kessler sold 33,765 shares of the business’s stock in a transaction that occurred on Friday, March 22nd. The shares were sold at an average price of $79.81, for a total value of $2,694,784.65. Following the completion of the sale, the chief executive officer now owns 126,635 shares of the company’s stock, valued at approximately $10,106,739.35. The disclosure for this sale can be found here. In the last ninety days, insiders sold 71,322 shares of company stock worth $5,682,895. 2.70% of the stock is currently owned by insiders.

Analysts Set New Price Targets

HQY has been the subject of several analyst reports. Barrington Research restated an “outperform” rating and issued a $100.00 target price on shares of HealthEquity in a research note on Friday, March 22nd. Barclays raised their target price on HealthEquity from $84.00 to $104.00 and gave the stock an “overweight” rating in a research note on Friday, February 23rd. Bank of America raised their target price on HealthEquity from $93.00 to $97.00 and gave the stock a “buy” rating in a research note on Wednesday, March 20th. KeyCorp raised their target price on HealthEquity from $85.00 to $95.00 and gave the stock an “overweight” rating in a research note on Friday, March 22nd. Finally, JMP Securities initiated coverage on HealthEquity in a research note on Thursday, April 4th. They issued a “mkt outperform” rating and a $101.00 target price for the company. One investment analyst has rated the stock with a hold rating and eleven have issued a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $96.17.

HealthEquity Stock Performance

NASDAQ:HQY opened at $80.38 on Wednesday. The business’s 50-day moving average price is $80.66 and its two-hundred day moving average price is $74.72. HealthEquity, Inc. has a twelve month low of $53.15 and a twelve month high of $84.49. The stock has a market cap of $6.90 billion, a P/E ratio of 125.59, a PEG ratio of 1.28 and a beta of 0.55. The company has a quick ratio of 4.76, a current ratio of 4.76 and a debt-to-equity ratio of 0.43.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings data on Tuesday, March 19th. The company reported $0.50 earnings per share for the quarter, beating analysts’ consensus estimates of $0.42 by $0.08. The company had revenue of $262.39 million for the quarter, compared to analysts’ expectations of $258.56 million. HealthEquity had a return on equity of 6.91% and a net margin of 5.57%. As a group, equities analysts predict that HealthEquity, Inc. will post 2.12 EPS for the current fiscal year.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.